PrimeRFP SCOUT · Federal Contract Recompete Brief

75D30123C17159FIELD TRIAL of fipronil-laced ORAL BAIT — Genesis Laboratories, Inc

Genesis Laboratories, Inc holds $620K across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Aug 24, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Cdc Office Of Acquisition Services

Awarding office

Genesis Laboratories, Inc

Recipient

Aug 24, 2026

PoP end

$620K

Obligated

$620K

Potential

541715

NAICS

AJ12

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Genesis Laboratories, Inc — $90

Contract facts

NONE

Contract number75D30123C17159

AgencyCdc Office Of Acquisition Services

Awarding officeCdc Office Of Acquisition Services

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentGenesis Laboratories, Inc

CAGE3A0Y6

UEIQ2RAMBFQRBV4

NAICS541715

PSCAJ12

Place of performanceWELLINGTON CO

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitation75D301-23-R-72772

PoP startAug 25, 2023

PoP end (current)Aug 24, 2026

Obligated$620K

Current value$620K

Potential value$620K

FIELD TRIAL OF FIPRONIL-LACED ORAL BAIT is a federal NONE award for Cdc Office Of Acquisition Services held by Genesis Laboratories, Inc. Estimated value $620K ($620K obligated). Current period of performance ends Aug 24, 2026. Last award drew 1 bidder. Place of performance: WELLINGTON CO. Related solicitation 75D301-23-R-72772.

Recompete timing

Public

● Past PoP end (14 days ago)

Current PoP ended Aug 24, 2026 (14 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Genesis Laboratories, Inc — $620K obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$620K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75D30123C17159?

75D30123C17159 (FIELD TRIAL of fipronil-laced ORAL BAIT) is a Cdc Office Of Acquisition Services award with a potential value of $620K, currently held by Genesis Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75D30123C17159?

Cdc Office Of Acquisition Services awarded 75D30123C17159 to Genesis Laboratories, Inc (potential $620K).

Who is the incumbent on 75D30123C17159?

Genesis Laboratories, Inc is the incumbent with $620K across 3 related awards in SCOUT’s public footprint. The current period of performance ends Aug 24, 2026.

When does Genesis Laboratories, Inc’s 75D30123C17159 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 24, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75D30123C17159 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 17, 2025